Corteria Pharmaceuticals

Phase 2

Paris, FranceFounded 2021corteriapharma.com

About us FOCUSED ON THE DEVELOPMENT OF TRANSFORMATIVE THERAPIES FOR THE TREATMENT OF WORSENING AND ACUTE DECOMPENSATED HEART FAILURE Founded in 2021, Corteria Pharmaceuticals is a privately held company developing first-in-class drugs for indications of high unmet medical need, such as heart failure, sarcopenia and obesity subpopulations. Our strategy implies innovative patient stratification and target […]

Founded

2021

Focus

Small Molecules

About

About us FOCUSED ON THE DEVELOPMENT OF TRANSFORMATIVE THERAPIES FOR THE TREATMENT OF WORSENING AND ACUTE DECOMPENSATED HEART FAILURE Founded in 2021, Corteria Pharmaceuticals is a privately held company developing first-in-class drugs for indications of high unmet medical need, such as heart failure, sarcopenia and obesity subpopulations. Our strategy implies innovative patient stratification and target […]

Funding History

2

Total raised: $75M

Series B$50MSofinnova PartnersSep 15, 2023

Series A$25MSofinnova PartnersJun 15, 2021

Company Info

TypePrivate

Founded2021

LocationParis, France

StagePhase 2

Contact

corteriapharma.com

Sectors

Small Molecule Drugs

SIMILAR COMPANIES

Phase 2 · Lille

Pre-clinical · Lyon

ABL Diagnostics

Pre-clinical · Strasbourg

Acticor Biotech

Pre-clinical · Paris

Pre-clinical · Lyon

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.